Aadi Bioscience, Inc. (AADI)

NASDAQ: AADI · IEX Real-Time Price · USD
13.69
-0.22 (-1.58%)
May 25, 2022 4:30 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2021202020192018201720162015
Revenue
1.1214.58020.16000
Revenue Growth (YoY)
-92.32%------
Gross Profit
1.1214.58020.16000
Selling, General & Admin
18.512.129.7613.499.245.270.02
Research & Development
19.6715.0112.8217.8512.1511.370
Other Operating Expenses
74.1601.860000
Operating Expenses
112.3417.1324.4431.3421.3916.630.02
Operating Income
-111.22-2.55-24.44-11.18-21.39-16.63-0.02
Interest Expense / Income
0.670.82000.110.480.01
Other Expense / Income
-1.790.11-1.17-0.78-0.09-0.130
Pretax Income
-110.09-3.48-23.27-10.4-21.4-16.98-0.03
Income Tax
0000000
Net Income
-110.09-3.48-23.27-10.4-21.4-16.98-0.03
Preferred Dividends
0.650.99000.943.930
Net Income Common
-110.74-4.47-23.27-10.4-22.34-20.91-0.03
Shares Outstanding (Basic)
9332100
Shares Outstanding (Diluted)
9332100
Shares Change
250.99%-6.04%19.62%56.56%2441.82%-82.95%-
EPS (Basic)
-12.41-1.76-8.55-4.65-15.45-367.80-0.15
EPS (Diluted)
-12.41-1.76-8.55-4.65-15.45-367.80-0.15
Free Cash Flow Per Share
-2.52-5.00-8.90-2.58-13.07-278.50-0.07
Gross Margin
100.00%100.00%-100.00%---
Operating Margin
-9930.09%-17.48%--55.47%---
Profit Margin
-9829.46%-23.85%--51.58%---
Free Cash Flow Margin
-2006.16%-87.11%--29.00%---
Effective Tax Rate
-0.00%-0.06%0.00%0.00%0.00%0.00%0.00%
EBITDA
-109.15-2.49-23.19-10.35-21.24-16.43-0.02
EBITDA Margin
-9745.27%-17.04%--51.35%---
EBIT
-109.42-2.66-23.27-10.4-21.29-16.5-0.02
EBIT Margin
-9769.91%-18.25%--51.58%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).